ProQR Therapeutics (PRQR) Net Cash Flow (QoQ) (2013 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 99.49% |
| Sep 30, 2022 | -263.49% |
| Jun 30, 2022 | 30.97% |
| Mar 31, 2022 | -168.23% |
| Dec 31, 2021 | 93.40% |
| Sep 30, 2021 | -79.52% |
| Jun 30, 2021 | 930.96% |
| Mar 31, 2021 | 23.69% |
| Dec 31, 2020 | -474.81% |
| Sep 30, 2020 | 132.62% |
| Jun 30, 2020 | -70,324.52% |
| Mar 31, 2020 | -100.04% |
| Dec 31, 2019 | 515.85% |
| Sep 30, 2019 | 19.31% |
| Jun 30, 2019 | 8.91% |
| Mar 31, 2019 | -147,705.09% |
| Dec 31, 2018 | -100.01% |
| Sep 30, 2018 | 1,538.21% |
| Jun 30, 2018 | -1,687,948.29% |
| Mar 31, 2018 | -98.75% |
| Dec 31, 2017 | 83,678.48% |
| Sep 30, 2017 | 100.00% |
| Jun 30, 2017 | -82,062.15% |
| Mar 31, 2017 | 100.03% |
| Dec 31, 2016 | -313,637.29% |
| Dec 31, 2015 | -372,917.76% |
| Mar 31, 2015 | 4.77% |
| Dec 31, 2014 | -106.82% |
| Mar 31, 2014 | -193.29% |
| Dec 31, 2013 | 390.53% |